Boston Research & Management Inc / TMO
Boston Research & Management Inc’s Thermo Fisher Scientific Inc Position
Does Boston Research & Management Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 10.8K shares worth $5M (+1.26% of its 13F portfolio) as of Q1 2026, up from 10.6K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
10.8K
% of Portfolio
+1.26%
Quarters Held
24
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 10.8K | $5M | +1.26% |
| Q4 2025 | 10.6K | $6M | +1.41% |
| Q3 2025 | 11.0K | $5M | +1.17% |
| Q2 2025 | 11.0K | $4M | +1.06% |
| Q1 2025 | 9.3K | $5M | +1.15% |
| Q4 2024 | 9.3K | $5M | +1.19% |
| Q3 2024 | 9.3K | $6M | +1.35% |
| Q2 2024 | 9.1K | $5M | +1.27% |
| Q1 2024 | 9.0K | $5M | +1.29% |
| Q4 2023 | 8.9K | $5M | +1.25% |
| Q3 2023 | 8.4K | $4M | +1.26% |
| Q2 2023 | 8.3K | $4M | +1.23% |
| Q1 2023 | 8.2K | $5M | +1.41% |
| Q4 2022 | 8.1K | $4M | +1.38% |
| Q3 2022 | 8.0K | $4M | +1.38% |
| Q2 2022 | 7.9K | $4M | +1.38% |
| Q1 2022 | 7.5K | $4M | +1.28% |
| Q4 2021 | 6.3K | $4M | +1.14% |
| Q3 2021 | 6.3K | $4M | +1.07% |
| Q2 2021 | 6.2K | $3M | +0.95% |
| Q1 2021 | 4.6K | $2M | +0.67% |
| Q4 2020 | 3.0K | $1M | +0.48% |
| Q3 2020 | 2.5K | $1M | +0.44% |
| Q2 2020 | 2.5K | $912,000 | +0.38% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Research & Management Inc’s full portfolio or all institutional holders of TMO.